Medical Design and Outsourcing Archives - Page 3 of 155

CytexOrtho shares the ‘secret sauce’ for its absorbable hip implants

CytexOrtho uses a three-dimensional weaving process to make its ReNew Hip implants. Shown here is a close-up of the woven textiles. [Image courtesy of CytexOrtho]

CytexOrtho is developing absorbable orthopedic implants with a unique manufacturing method to help a rapidly growing patient population.

The ReNew Hip implant developer won the inaugural OrthoPitch tech innovation competition at AAOS 2024, beating out more than 40 other nominees.

CytexOrtho co-founder and CEO Brad Estes said the startup has filed its FDA investigational device exemption (IDE) for a phase one clinical trial in the U.S., he told Medical Design & Outsourcing after his recent DeviceTalks Weekly interview. The company plans to seek FDA premarket approval (PMA) after a larger phase two pivotal trial.

DeviceTalks live and in person: Registration is now open for DeviceTalks Boston (May 1-2)

CytexOrtho (incorporated as…

How syncing wearables with AI chatbots can accelerate recovery time

Smart integration of AI chatbots and data collected by wearable devices can help patients and health care providers respond to early signs of illness.

By Nate MacLeitch, QuickBlox

[Illustration by Kudryavtsev via Stock.Adobe.com]

More effective public health and medical interventions could save 1.2 million lives per year, according to the Organization for Economic Cooperation and Development (OECD).

But the healthcare industry isn’t solely responsible. There is usually a gap between identifying an illness and seeking medical attention. Even when a patient feels unwell, they often don’t know the best path of care and may avoid medical support because they minimize their symptoms, lack physical access to local healthcare, worry about healthcare costs, or simply don’t have a doctor.

Wearable medical devices can bridge this gap by monitoring vital signs — often remotely — to determine irregular behavi…

Allegheny Performance Plastics enters the medtech market

NEWS RELEASE: Allegheny Launches into Healthcare Sector

Leetsdale, Pennsylvania, March 2024: To meet the growing needs of the healthcare industry, Allegheny Performance Plastics is proud to announce the addition of clean and white room environments, including a dedicated automated work cell to be completed later this year. The healthcare industry, with services spanning preventative care, diagnostics, treatment, rehabilitation and support, encompasses many applications that are a natural fit for injection molding high-performance materials. The unique customer experience delivered by Allegheny guarantees the precision, reliability, and performance required for medical applications. Learn more about our five-step manufacturing process by visiting the website here.

“Our technical expertise and manufacturing capabilities have proven valuable in the healthcare industry,” said Rob Stutzman, Allegheny Chief Executive Officer. “Our entire team is excited to meet the challenges …

Understanding medtech AI with alpacas, llamas and Hologic VP of R&D/Innovation Mike Quick

The difference between llamas and alpacas is a great way to talk about medtech AI, Hologic VP of R&D/Innovation Mike Quick says. [Photo by linaskk via Stock.Adobe.com]

When Hologic VP of R&D/Innovation Mike Quick talks about artificial intelligence and medtech AI, he draws on his personal experience as an amateur alpaca farmer.

He and his wife had a herd of nearly a dozen alpaca when they lived in the Boston area. Then they moved to Arizona, where they now have three alpaca on a small farm in Phoenix.

“They’re a lot of fun,” he said in an interview with Medical Design & Outsourcing. “… The difference between llamas and alpacas — because it’s a common misconception of what they are — is a great way to talk about AI and the difference between machine learning and deep learning and how to learn to tell two different things apart.”

You start with t…

Isometric Micro Molding closes sale to new owner Nissha Medical Technologies

Isometric Micro Molding manufactures miniaturized parts and components for medical devices. [Photo courtesy of Isometric Micro Molding]

Isometric Micro Molding is officially under new ownership after Nissha Medical Technologies closed on its acquisition of the medtech supplier.

Buffalo, New York–based Nissha Medical Technologies (a subsidiary of Kyoto, Japan-based Nissha Co.) is a contract development and manufacturing organization (CDMO) focused on minimally invasive surgical instruments and wearable devices.

Under terms announced in December, Nissha planned to take a majority stake in Isometric Intermediate LLC., which owns the Isometric group of companies. Other financial terms have not been disclosed.

“We’re excited to add another vertically integrated capability as a global CDMO supporting miniaturization of devices and components,” Nissha Medical Technologies said in a post on Li…

This novel catheter system could yield safer transseptal procedures

The UltraNav Transseptal Catheter System houses transeptal needles and wires with the intracardiac echocardiography catheter, optimizing safety and efficacy of transseptal procedures

By Nabil Dib, Dib UltraNav Medical

The Dib UltraNav Transseptal Catheter System [Photo courtsy of Dib UltraNav Medical]

Cardiologists conducted approximately 375,000 transseptal left heart procedures for closures, valvuloplasty, repairs, septostomies, and electrophysiology in 2021. It is estimated that around 900,000 transseptal heart procedures will be performed in 2025.

The significant rise in procedure volume presents both challenges and opportunities.

The challenges include a correlated rise in procedural complications. Even though the percentage of procedures with complications is overall very low — 1-2% of procedures involving transesophageal echo (TEE), for example, result in unintended perforations — the rapid…

Dri-Air launches MD (MicroDryer) Series

NEWS RELEASE: Dri-Air Introduces the MD (MicroDryer) Series On Display at NPE 2024 – Booth W909

Dri-Air said its MicroDryer compressed air dryers are designed for very low throughputs, with hopper capacity ranging from 1 to 15 lbs. [Photo courtesy of Dri-Air]

East Windsor, CT, February 29, 2024 – Dri-Air Industries, Inc is pleased to introduce a new product series in their extensive dryer line for the plastics industry. Known throughout the industry for their desiccant dryers, Dri-Air is now manufacturing a micro line of compressed air dryers with matching hoppers.

The MicroDryer Series (MD) is a line of sleek, compressed air dryers designed for very low throughputs. The series of dryers start with the MD-1 equipped with drying hoppers with a capacity of 1-3 lbs and range up to the MD-3 with the largest capacity of 15 lbs. Low dewpoints, -40F and below, are assured as the dryer is equipped with a membrane and…

Zeus sale to private equity firm EQT closes

Zeus is officially under new ownership after private equity firm EQT closed on its acquisition of the medical tubing supplier.

“Today marks the start of a new chapter for our company, and we’re excited to share this update with you,” Zeus said in an email to “industry partners” announcing the deal’s finalization. “We believe this partnership will allow us to continue to grow and create innovative products to help our customers be successful. We remain focused on our people, our customers, and our partners.”

With the transaction’s closing, former Hillrom CEO John Groetelaars is now Zeus’ executive chair.

EQT and Zeus have not released the purchase price or other terms of the deal. Bloomberg reported in December that the deal valued Zeus at $3.4 billion, citing unidentified “people with knowledge of the matter.”

Earlier this week, EQT said their EQT X target fund hit a hard ca…

Covestro publishes climate neutrality targets for scope 3 emissions

NEWS RELEASE: Covestro publishes climate neutrality targets for scope 3 emissions Reduction of 10 million metric tons of greenhouse gases produced in upstream and downstream supply chains (scope 3) by 2035, climate neutrality for scope 3 by 2050 Climate strategy for reducing greenhouse gases complete Concrete plan for implementation to reduce emissions, transformation along the entire supply chain required

PITTSBURGH, February 29, 2024 — Covestro has published its climate neutrality targets for scope 3 emissions, completing its climate strategy for reducing greenhouse gas emissions. As a short-term goal, the company plans to reduce greenhouse gases by 10 million metric tons by 2035. This corresponds to a drop in emissions of 30 percent compared to the base year 2021, with some growth-related emissions through 2035 included in the calculation. In the long-term, Covestro plans to be climate-neutral in terms of scope 3 emissions by 2050.

Covestro previously publ…

What Synchron leaders learned from developing a stent-based BCI

This close-up shows one of the electrodes on Synchron’s Stentrode brain implant. [Image courtesy of Synchron]

Synchron’s efforts to develop, manufacture and commercialize its groundbreaking brain-computer interface system holds lessons for device developers who are designing increasingly miniaturized implants for minimally invasive delivery.

In recent months and years, we’ve asked Synchron leaders to share their advice as they studied the safety of their nitinol Stentrode implant, refined the implant’s design and manufacturing process, and launched a clinical trial under an investigational device exemption from the FDA, which previously awarded Synchron with breakthrough device designation.

‘Take it step by step’

In a wide-ranging interview with Medical Design & Outsourcing, Synchron CEO and co-founder Dr. Tom Oxley offered some advice specifically for device desig…

March 2024: Medtronic AI, Ortho tech at AAOS 2024 and Abbott PFA

How Medtronic’s using AI: Artificial intelligence insights and advice Abbott bets on balloons in the pulsed field ablation battle How Noah Medical’s robotic Galaxy system goes deep into the lungs The biggest stories from AAOS 2024 Surgical robots don’t improve knee surgery revision rates, study says Seize the AI opportunity

Less than a year into his new role as Medtronic’s chief technology and innovation officer, Ken Washington was presenting on artificial intelligence to leaders of the company’s operating units.

One of the GMs stopped him and asked for help making sense of all the buzzwords and acronyms.

Perhaps you know the feeling. It’s hard to grasp how AI seems to be everywhere, with advanced computing power making sense of vast datasets. It’s in the voice assistants on our smartphones, the streaming services on our various screens, mapping systems in our cars, the chat bots who respond when we need customer service, and online services ra…

Select an optimal motor for your benchtop point-of-care testing device

Brushless DC motors are a promising alternative to traditionally favored stepper and DC motors in point-of-care testing devices, and each technology offers distinct advantages for some applications.

By Dan Cisier, Portescap

Portescap’s 20DAM-K digital linear actuator [Photo courtesy of Portescap]

In life-and-death medical situations, rapid and dependable sample testing is pivotal in ensuring fast and accurate treatments.

In the past, procedures like blood and urine sample testing traditionally required intricate equipment and highly trained technicians at specialized labs outside healthcare settings.

In order to deliver prompt and dependable outcomes, this conventional testing approach had to overcome hurdles such as sample transportation, potential congestion at testing facilities and shortages of technical experts. During the COVID-19 crisis, for example, PCR test results sometimes took se…